Document is current

Any future updates will be listed below

Assessing pharmacokinetics and drug-drug interactions of the combination therapy of myelofibrosis with ruxolitinib and lenalidomide by a new eco-friendly HPLC method for their simultaneous determination in plasma

Crossref DOI link: https://doi.org/10.1007/s00280-024-04715-y

Published Online: 2024-09-11

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark